Precipitated and spontaneous withdrawal in rats tolerant to anandamide

被引:33
作者
Costa, B
Giagnoni, G
Colleoni, M
机构
[1] Univ Milano Bicocca, Fac Sci MM FF NN, Inst Pharmacol, I-20129 Milan, Italy
[2] Univ Milano Bicocca, Fac Sci, Dept Biotechnol & Biosci, I-20126 Milan, Italy
关键词
anandamide; behavioral tolerance; SR141716A; precipitated and spontaneous withdrawal;
D O I
10.1007/s002139900360
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: There is evidence that cannabinoids cause tolerance and physical dependence in humans and animals. Objectives: The aim of this work was to study whether the endogenous ligand for the cannabinoid receptor, arachidonylethanolamide (anandamide), induced behavioral tolerance and physical dependence in rats. Methods: Rats were injected with anandamide (20 mg/kg IF) daily for 2 weeks. To assess tolerance, on days 1, 8 and 15 of treatment rats were observed and behavior was tested. Two common methods were employed to assess physical dependence: interruption of anandamide dosing and vehicle substitution or administration of the cannabinoid CB1 receptor antagonist SR141716A (3 mg/kg IF). Results: Full or partial tolerance developed to the classical behavioral effects elicited by the cannabinoids: hypothermia, catalepsy, hypomotility, decrease in stereotypic activity (rearing and grooming) and hindlimb splaying. No tolerance to anandamide was observed for reduced defecation. An abstinence syndrome appeared after abrupt cessation of cannabinoid intake and after withdrawal precipitated by SR141716A; the withdrawal signs were scratching, licking and biting, eating of feces, ptosis, arched back, wet dog shakes, head shakes, myoclonic spasms, writhing, forepaw fluttering, teeth chattering and piloerection. Conclusions: These findings indicate that the endogenous cannabinoid ligand, administered exogenously, induces both tolerance and physical dependence in rats.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 46 条
[1]  
Aceto MD, 1998, J PHARMACOL EXP THER, V287, P598
[2]   CANNABINOID PRECIPITATED WITHDRAWAL BY THE SELECTIVE CANNABINOID RECEPTOR ANTAGONIST, SR 141716A [J].
ACETO, MD ;
SCATES, SM ;
LOWE, JA ;
MARTIN, BR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 282 (1-3) :R1-R2
[3]  
Aceto MD, 1996, J PHARMACOL EXP THER, V278, P1290
[4]  
Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209
[5]  
Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x
[6]   TOLERANCE TO EFFECTS OF DELTA9-TETRAHYDROCANNABINOL IN MICE ON INTESTINAL MOTILITY, TEMPERATURE AND LOCOMOTOR ACTIVITY [J].
ANDERSON, PF ;
JACKSON, DM ;
CHESHER, GB ;
MALOR, R .
PSYCHOPHARMACOLOGIA, 1975, 43 (01) :31-36
[7]  
[Anonymous], PHARM MARIHUANA
[8]  
BEARDSLEY PM, 1986, J PHARMACOL EXP THER, V239, P311
[9]   Functional role of high-affinity anandamide transport, as revealed by selective inhibition [J].
Beltramo, M ;
Stella, N ;
Calignano, A ;
Lin, SY ;
Makriyannis, A ;
Piomelli, D .
SCIENCE, 1997, 277 (5329) :1094-1097
[10]   Cannabis and endogenous cannabinoid systems [J].
Childers, SR ;
Breivogel, CS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :173-187